The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01574651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

934

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: QVA149
DRUG: Placebo to tiotropium
DRUG: Placebo to formoterol
DRUG: Tiotropium
DRUG: Formoterol
DRUG: Placebo to QVA149

Sponsor

Novartis Pharmaceuticals